{"product_id":"blood-bank-center-kpi-metrics","title":"7 Essential KPIs for Blood Bank Financial Health","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eKPI Metrics for Blood Bank\u003c\/h2\u003e\n\u003cp\u003eManaging a Blood Bank requires balancing critical inventory control with high fixed costs and regulatory compliance You must track 7 core metrics covering unit economics, operational efficiency, and liquidity For example, Packed Red Cells sell for $450 in 2026, driving significant revenue Your goal is to keep the Gross Margin high—above \u003cstrong\u003e90%\u003c\/strong\u003e—by controlling unit costs like reagents and labor Focus on achieving operational efficiency quickly the model shows you hit breakeven in just 1 month, but you must maintain this momentum by reviewing inventory and wastage weekly\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 KPIs to Track for \u003c\/span\u003eBlood Bank\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eKPI Name\u003c\/th\u003e\n\u003cth\u003eMetric Type\u003c\/th\u003e\n\u003cth\u003eTarget \/ Benchmark\u003c\/th\u003e\n\u003cth\u003eReview Frequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eInventory Wastage Rate\u003c\/td\u003e\n\u003ctd\u003ePercentage (Wasted Units \/ Total Collected Units)\u003c\/td\u003e\n\u003ctd\u003eAim for below 5%\u003c\/td\u003e\n\u003ctd\u003eDaily\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eGross Margin Percentage (GM%)\u003c\/td\u003e\n\u003ctd\u003ePercentage ((Revenue - Unit COGS) \/ Revenue)\u003c\/td\u003e\n\u003ctd\u003eTarget above 90%\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eDonor Acquisition Cost (DAC)\u003c\/td\u003e\n\u003ctd\u003eDollar Cost (Total Marketing Spend \/ New Successful Donors)\u003c\/td\u003e\n\u003ctd\u003eTarget under $100\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eCost Per Component Unit\u003c\/td\u003e\n\u003ctd\u003eDollar Cost (Sum of unit costs, eg, $40 for PRC)\u003c\/td\u003e\n\u003ctd\u003eTrack sum of unit costs\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eComponent Yield Rate\u003c\/td\u003e\n\u003ctd\u003ePercentage (Total Components Produced \/ Total Whole Blood Units Collected)\u003c\/td\u003e\n\u003ctd\u003eTargeting above 95%\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eOperating Cash Cycle (OCC)\u003c\/td\u003e\n\u003ctd\u003eDays (DIO + DSO - DPO)\u003c\/td\u003e\n\u003ctd\u003eTargeting under 60 days\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eRevenue Mix Concentration\u003c\/td\u003e\n\u003ctd\u003ePercentage (Revenue from Top Products \/ Total Revenue)\u003c\/td\u003e\n\u003ctd\u003eAssess diversification risk\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow do I structure my pricing and cost of goods sold (COGS) to maximize gross profitability?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eTo maximize gross profitability on your \u003cstrong\u003e$450\u003c\/strong\u003e Packed Red Cell (PRC) sales, you must confirm your fully burdened unit cost stays below \u003cstrong\u003e$45\u003c\/strong\u003e to meet the 90% margin goal, factoring in every expense like the \u003cstrong\u003e$15\u003c\/strong\u003e testing reagent fee.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eUnit Cost vs. Target Margin\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTarget COGS for 90% margin on $450 is \u003cstrong\u003e$45\u003c\/strong\u003e per unit.\u003c\/li\u003e\n\u003cli\u003eThe \u003cstrong\u003e$15\u003c\/strong\u003e reagent cost consumes \u003cstrong\u003e33%\u003c\/strong\u003e of your allowable COGS budget.\u003c\/li\u003e\n\u003cli\u003eYou must calculate all direct labor and overhead allocated per unit.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises, impacting fixed cost absorption.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eModeling Profitability Levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIf non-reagent costs are $25, total COGS hits $40, yielding only \u003cstrong\u003e11.1%\u003c\/strong\u003e margin.\u003c\/li\u003e\n\u003cli\u003eYou defintely need to drive down processing time or secure lower reagent rates.\u003c\/li\u003e\n\u003cli\u003eModel the impact of increasing volume to dilute fixed facility overhead costs.\u003c\/li\u003e\n\u003cli\u003eExplore volume discounts on consumables used during collection and processing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre my operational efficiencies scaling fast enough to outpace rising fixed and labor costs?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYour operational efficiency for the Blood Bank hinges on whether adding \u003cstrong\u003e20 more Medical Technologists\u003c\/strong\u003e by 2030, pushing labor costs up, is justified by the projected \u003cstrong\u003e4x growth\u003c\/strong\u003e in PRC units from 2,000 to 8,000; this balancing act is critical for profitability, a dynamic similar to what we see when analyzing margins in related medical supply chains, as detailed in \u003ca href=\"\/blogs\/how-much-makes\/blood-bank-center\"\u003eHow Much Does The Owner Of Blood Bank Make?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLabor Cost vs. Volume Throughput\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIf current annual labor cost is \u003cstrong\u003e$625,000\u003c\/strong\u003e, you need to know the current throughput per FTE.\u003c\/li\u003e\n\u003cli\u003eProjected growth requires PRC units to hit \u003cstrong\u003e8,000\u003c\/strong\u003e, up from 2,000, while FTEs double from 20 to 40.\u003c\/li\u003e\n\u003cli\u003eThis means you must defintely process \u003cstrong\u003e4x the volume\u003c\/strong\u003e with 2x the staff, requiring a 2x efficiency gain per technologist.\u003c\/li\u003e\n\u003cli\u003eCheck if processing \u003cstrong\u003e4,600 total units\u003c\/strong\u003e in 2026 supports the current labor spend structure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eQuality Control Overhead Risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eQuality Control Overhead is currently pegged at only \u003cstrong\u003e0.1%\u003c\/strong\u003e of total revenue.\u003c\/li\u003e\n\u003cli\u003eThis percentage is extremely lean for a highly regulated operation handling life-saving components.\u003c\/li\u003e\n\u003cli\u003eIf revenue targets are missed, this small overhead allocation provides almost no buffer for unexpected compliance costs.\u003c\/li\u003e\n\u003cli\u003eModel the impact if QC spending needs to increase to \u003cstrong\u003e0.5%\u003c\/strong\u003e of revenue to maintain compliance standards.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the true cost of acquiring and retaining donors, and how does it affect long-term viability?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe true cost of running a sustainable Blood Bank operation is measured by whether your Donor Acquisition Cost (DAC) is dwarfed by the Lifetime Value (LTV) of a donor who gives repeatedly, meaning the current $3,000 monthly marketing spend must secure a high volume of loyal donors, not just one-timers.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAcquisition Cost vs. Volume Needs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIf the \u003cstrong\u003e$3,000\u003c\/strong\u003e monthly marketing budget secures \u003cstrong\u003e150\u003c\/strong\u003e new donors, the DAC is \u003cstrong\u003e$20\u003c\/strong\u003e per person.\u003c\/li\u003e\n\u003cli\u003eTo cover \u003cstrong\u003e$120,000\u003c\/strong\u003e in fixed overhead, you need a contribution margin of \u003cstrong\u003e80%\u003c\/strong\u003e on unit sales.\u003c\/li\u003e\n\u003cli\u003eIf the average unit price is $300, you need to process about \u003cstrong\u003e500 units\u003c\/strong\u003e monthly just to cover fixed costs before acquisition.\u003c\/li\u003e\n\u003cli\u003eThis means acquisition must drive enough volume to push sales past the \u003cstrong\u003e$150,000\u003c\/strong\u003e revenue threshold quickly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRetention Drives Long-Term Value\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFirst-time donors retained at only \u003cstrong\u003e30%\u003c\/strong\u003e have a low LTV, making a $20 DAC potentially too high for that segment.\u003c\/li\u003e\n\u003cli\u003eEstablished donors retained at \u003cstrong\u003e75%\u003c\/strong\u003e give 2.5 units annually, which is defintely where the long-term viability lives, as seen when analyzing how much the owner of a Blood Bank makes.\u003c\/li\u003e\n\u003cli\u003eTo be safe, your DAC should ideally be less than \u003cstrong\u003e20% of LTV\u003c\/strong\u003e; if LTV is $1,500, you can spend up to $300 per donor.\u003c\/li\u003e\n\u003cli\u003eIf the community onboarding process drags past \u003cstrong\u003e14 days\u003c\/strong\u003e, the initial commitment often fades, spiking effective acquisition costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow exposed is the business to volatility if demand shifts away from high-margin products?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Blood Bank's 2026 revenue is heavily concentrated in standard components, so a failure in the high-priced Rare Blood Typing segment won't immediately crater the business, but managing Fresh Frozen Plasma inventory is defintely crucial for operational stability. Before diving into the numbers, remember that regulatory compliance is key; \u003ca href=\"\/blogs\/how-to-open\/blood-bank-center\"\u003eHave You Considered The Necessary Licenses And Certifications To Launch Blood Bank Successfully?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue Concentration Risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003e2026 revenue relies heavily on two core products.\u003c\/li\u003e\n\u003cli\u003ePacked Red Cells account for $\u003cstrong\u003e900,000\u003c\/strong\u003e in projected sales.\u003c\/li\u003e\n\u003cli\u003ePlatelets contribute $\u003cstrong\u003e600,000\u003c\/strong\u003e to the total forecast.\u003c\/li\u003e\n\u003cli\u003eIf Rare Blood Typing units ($\u003cstrong\u003e800\u003c\/strong\u003e\/unit) fail to grow, the impact is localized.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInventory Stability Levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFocus inventory management on critical, short-shelf-life items.\u003c\/li\u003e\n\u003cli\u003eEstablish a minimum safety stock level for Fresh Frozen Plasma.\u003c\/li\u003e\n\u003cli\u003eThis buffer protects against immediate supply chain shocks.\u003c\/li\u003e\n\u003cli\u003eWe must ensure stock covers at least \u003cstrong\u003e7 days\u003c\/strong\u003e of average usage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003ePrioritize maintaining a Gross Margin above 90% by rigorously controlling unit COGS relative to component selling prices.\u003c\/li\u003e\n\n\u003cli\u003eDaily monitoring of the Inventory Wastage Rate, targeting below 5%, is critical for protecting profitability due to component shelf-life constraints.\u003c\/li\u003e\n\n\u003cli\u003eOperational efficiency must scale rapidly, comparing processed volume against rising labor costs to ensure the projected $736,000 Year 1 EBITDA is achieved.\u003c\/li\u003e\n\n\u003cli\u003eLong-term viability depends on managing Donor Acquisition Cost (DAC) and assessing Revenue Mix Concentration to mitigate risks associated with demand shifts.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 1\n: \u003cspan style=\"color: #126CFF;\"\u003eInventory Wastage Rate\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eInventory Wastage Rate measures how much collected blood you lose before it gets used, and keeping this below \u003cstrong\u003e5%\u003c\/strong\u003e daily is critical for profitability. This metric tracks the percentage of collected blood units that expire or fail quality control checks. For a blood bank, this number directly impacts your available supply and, therefore, your revenue potential.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIdentifies process bottlenecks immediately.\u003c\/li\u003e\n\u003cli\u003eProtects high \u003cstrong\u003eGross Margin Percentage (GM%)\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eDrives better inventory scheduling decisions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCan be skewed by rare blood type availability issues.\u003c\/li\u003e\n\u003cli\u003eDaily review requires robust, real-time tracking systems.\u003c\/li\u003e\n\u003cli\u003eA low rate doesn't guarantee efficient component yield.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe target for this industry is keeping wastage below \u003cstrong\u003e5%\u003c\/strong\u003e. Some high-efficiency centers aim for \u003cstrong\u003e3%\u003c\/strong\u003e or less. Hitting this benchmark ensures you maximize the value from every donor interaction, which is key since \u003cstrong\u003eDonor Acquisition Cost (DAC)\u003c\/strong\u003e is a real expense.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eImplement predictive modeling to match collection schedules to hospital demand forecasts.\u003c\/li\u003e\n\u003cli\u003eOptimize processing time to maximize component shelf life, aiming for faster component yield.\u003c\/li\u003e\n\u003cli\u003eEstablish strict, daily inventory rotation protocols based on expiration dates.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by dividing the total number of units thrown away by the total number collected over the same period. This is a straightforward ratio that needs constant monitoring.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nInventory Wastage Rate = (Wasted Units \/ Total Collected Units)\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay you collected \u003cstrong\u003e1,000\u003c\/strong\u003e whole blood units last week, but \u003cstrong\u003e45\u003c\/strong\u003e units expired or failed testing. The wastage rate is \u003cstrong\u003e4.5%\u003c\/strong\u003e, which is good, but still needs daily attention.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nInventory Wastage Rate = (45 Wasted Units \/ 1,000 Total Collected Units) = \u003cstrong\u003e4.5%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTie wastage reporting directly to the weekly review of \u003cstrong\u003eCost Per Component Unit\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAnalyze waste reasons (QC failure vs. expiration) separately for better fixes.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes \u003cstrong\u003e14+ days\u003c\/strong\u003e, churn risk rises among new donors; defintely speed this up.\u003c\/li\u003e\n\u003cli\u003eEnsure your logistics platform tracks component shelf life down to the hour.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 2\n: \u003cspan style=\"color: #126CFF;\"\u003eGross Margin Percentage (GM%)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage (GM%) shows how much revenue remains after paying for the direct costs of producing your service or product. For VitalFlow Solutions, this measures the core profitability of selling processed blood components like Packed Red Cells or Fresh Frozen Plasma. You must target GM% \u003cstrong\u003eabove 90%\u003c\/strong\u003e; anything less means you aren't covering your fixed overhead efficiently.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eQuickly reveals pricing power versus direct processing costs.\u003c\/li\u003e\n\u003cli\u003eShows the immediate impact of efficiency gains on unit profitability.\u003c\/li\u003e\n\u003cli\u003eIt’s the purest measure of your core operational markup.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt completely ignores fixed overhead costs like facility rent.\u003c\/li\u003e\n\u003cli\u003eIt can mask problems if Unit COGS calculations miss indirect variable costs.\u003c\/li\u003e\n\u003cli\u003eIt doesn't account for inventory risk tied to spoilage (Inventory Wastage Rate).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor highly specialized medical processing where input (donation) is donated but processing is complex, the benchmark is high. While standard manufacturing might see 30% to 50% GM%, your target of \u003cstrong\u003eabove 90%\u003c\/strong\u003e is appropriate for a high-value, regulated service. If you see a dip below \u003cstrong\u003e88%\u003c\/strong\u003e, you need to investigate immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDrive up the \u003cstrong\u003eComponent Yield Rate\u003c\/strong\u003e to maximize sellable units per donation.\u003c\/li\u003e\n\u003cli\u003eNegotiate volume discounts on expensive reagents and testing kits.\u003c\/li\u003e\n\u003cli\u003eReduce spoilage, which directly lowers Unit COGS and boosts margin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate GM% by taking total revenue, subtracting the direct costs associated with producing those units (Unit COGS), and dividing that result by the revenue. This tells you the percentage of every dollar earned that remains before overhead hits.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n(Revenue - Unit COGS) \/ Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay you sell 1,000 units of plasma this month for $400 each, totaling $400,000 in Revenue. If the variable cost to test, process, and package those units (Unit COGS) was $35,000, your gross profit is $365,000. Here’s the quick math to hit your target:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n($400,000 Revenue - $35,000 Unit COGS) \/ $400,000 Revenue = \u003cstrong\u003e91.25% GM%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric \u003cstrong\u003emonthly\u003c\/strong\u003e to catch cost creep early.\u003c\/li\u003e\n\u003cli\u003eCompare GM% against the \u003cstrong\u003eCost Per Component Unit\u003c\/strong\u003e to isolate cost drivers.\u003c\/li\u003e\n\u003cli\u003eIf GM% is high but cash flow is tight, check your \u003cstrong\u003eOperating Cash Cycle\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eTrack GM% by component type; plasma might be \u003cstrong\u003e95%\u003c\/strong\u003e while platelets lag at \u003cstrong\u003e85%\u003c\/strong\u003e, defintely requiring action.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 3\n: \u003cspan style=\"color: #126CFF;\"\u003eDonor Acquisition Cost (DAC)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDonor Acquisition Cost (DAC) tracks the average marketing and outreach expense required to secure one successful donor. It’s crucial because high acquisition costs erode the high gross margins expected from selling processed blood products. We must target keeping this figure under \u003cstrong\u003e$100\u003c\/strong\u003e per donor, reviewing the total spend every quarter.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eLinks outreach spending directly to donor volume.\u003c\/li\u003e\n\u003cli\u003eEnsures marketing efficiency against unit production costs.\u003c\/li\u003e\n\u003cli\u003eHelps identify which community campaigns yield the best results.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores donor retention rates over time.\u003c\/li\u003e\n\u003cli\u003eDoesn't capture processing or testing costs post-acquisition.\u003c\/li\u003e\n\u003cli\u003eCan lead to chasing cheap, low-commitment donors if the target is too rigid.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor mission-based acquisition, benchmarks vary widely, but for a critical service like blood supply, you need efficiency. While general customer acquisition costs can exceed $500, mission-driven organizations often aim for a DAC under \u003cstrong\u003e$100\u003c\/strong\u003e, especially since the product has high inherent value once processed. If your DAC hits $150, you’re spending too much relative to the expected lifetime value of a repeat donor.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDouble down on referral programs from existing donors.\u003c\/li\u003e\n\u003cli\u003eOptimize digital ads to improve conversion rates on sign-ups.\u003c\/li\u003e\n\u003cli\u003ePartner with local employers for on-site drives to cut outreach costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find DAC, divide all marketing and outreach expenses by the number of new donors who successfully completed their first donation during that period. This metric tells you the true cost of expanding your donor base.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nTotal Marketing Spend \/ New Successful Donors\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay in the first quarter, you spent \u003cstrong\u003e$50,000\u003c\/strong\u003e across digital ads, community events, and direct mail. This effort resulted in \u003cstrong\u003e650\u003c\/strong\u003e new successful donors who completed their first viable donation. Here’s the quick math:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n$50,000 \/ 650 Donors = $76.92 DAC\n\u003c\/div\u003e\n\u003cp\u003eThis result of \u003cstrong\u003e$76.92\u003c\/strong\u003e is below your target of $100, which is a good start for scaling outreach.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment DAC by acquisition channel (e.g., social media vs. local event).\u003c\/li\u003e\n\u003cli\u003eDefine 'Successful Donor' as someone who completes a viable donation, not just signs up.\u003c\/li\u003e\n\u003cli\u003eTrack marketing spend weekly, but report DAC quarterly as planned.\u003c\/li\u003e\n\u003cli\u003eIf donor onboarding takes 14+ days, churn risk rises defintely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 4\n: \u003cspan style=\"color: #126CFF;\"\u003eCost Per Component Unit\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCost Per Component Unit (CPCU) shows your total variable expense to ready one blood product for shipment. This includes the cost of labor used in processing and the specific reagents needed for that component. We review this metric \u003cstrong\u003eweekly\u003c\/strong\u003e because small variances here directly impact your ability to hit that target \u003cstrong\u003e90%\u003c\/strong\u003e Gross Margin Percentage.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoints variable production inefficiencies immediately.\u003c\/li\u003e\n\u003cli\u003eDrives negotiations on reagent and supply contracts.\u003c\/li\u003e\n\u003cli\u003eProvides the COGS input needed for accurate pricing decisions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores fixed overhead costs like facility depreciation.\u003c\/li\u003e\n\u003cli\u003eCan mask quality issues if labor is rushed to lower the cost.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for the cost of initial collection or donor acquisition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized medical processing like this, benchmarks are component-specific, but the goal is always cost minimization relative to the selling price. If your average selling price per unit is \u003cstrong\u003e$250\u003c\/strong\u003e, you need your CPCU to be substantially lower to maintain that high gross margin. If your CPCU creeps above \u003cstrong\u003e$50\u003c\/strong\u003e, you defintely need to investigate processing labor utilization right away.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStandardize labor allocation time per component type.\u003c\/li\u003e\n\u003cli\u003eImplement batch processing for high-volume components like PRC.\u003c\/li\u003e\n\u003cli\u003eRenegotiate supply contracts based on projected annual volume commitments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate CPCU by adding up all the direct variable costs associated with turning collected whole blood into a final, sellable component. This is a summation of the unit costs involved in that specific transformation step.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCPCU = Labor Cost per Unit + Reagent Cost per Unit + Direct Processing Supplies per Unit\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eLet’s look at Packed Red Cells (PRC). If the direct labor time to process one unit costs \u003cstrong\u003e$15\u003c\/strong\u003e, and the specialized reagents needed cost \u003cstrong\u003e$25\u003c\/strong\u003e, the total variable cost per unit is calculated directly.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCPCU (PRC) = $15 (Labor) + $25 (Reagents) = $40\n\u003c\/div\u003e\n\u003cp\u003eThis means it costs you \u003cstrong\u003e$40\u003c\/strong\u003e in variable inputs to create one unit of PRC before considering waste or overhead.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack labor time against the Component Yield Rate to find bottlenecks.\u003c\/li\u003e\n\u003cli\u003eSegment CPCU by component type (PRC vs. FFP) for targeted cost reduction.\u003c\/li\u003e\n\u003cli\u003eSet a target cost floor for each component based on historical best performance.\u003c\/li\u003e\n\u003cli\u003eReview reagent usage logs weekly against standard operating procedure volumes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 5\n: \u003cspan style=\"color: #126CFF;\"\u003eComponent Yield Rate\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eComponent Yield Rate measures how efficiently you convert collected whole blood units into sellable, processed components like plasma or red cells. This metric is crucial because it directly ties processing skill to potential revenue generation from every donation secured. Hitting the target of \u003cstrong\u003eabove 95%\u003c\/strong\u003e means you are maximizing the value extracted from your raw material.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoints processing bottlenecks immediately upon review.\u003c\/li\u003e\n\u003cli\u003eMaximizes revenue potential per whole blood unit collected.\u003c\/li\u003e\n\u003cli\u003eLowers the effective Cost Per Component Unit produced.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCan incentivize speed over careful handling during separation.\u003c\/li\u003e\n\u003cli\u003eDoes not account for component quality or shelf-life post-processing.\u003c\/li\u003e\n\u003cli\u003eRequires rigorous, real-time tracking of every unit processed and lost.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor advanced processing centers aiming for supply chain reliability, the benchmark is aggressive, targeting \u003cstrong\u003eabove 95%\u003c\/strong\u003e yield. Centers with older separation equipment or less standardized protocols might see yields closer to 90% or less. Consistently missing the 95% mark suggests equipment calibration or technician training needs immediate review.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStandardize centrifuge protocols across all processing shifts.\u003c\/li\u003e\n\u003cli\u003eInvest in preventative maintenance for separation machinery calibration.\u003c\/li\u003e\n\u003cli\u003eMandate weekly yield variance review by the processing team lead.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this efficiency ratio by dividing the total number of usable components you successfully extract by the total volume of whole blood you started with. This tells you the raw material conversion rate.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nComponent Yield Rate = (Total Components Produced \/ Total Whole Blood Units Collected)\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your center collected \u003cstrong\u003e1,000\u003c\/strong\u003e whole blood units last week. If your processing team successfully separated and passed quality checks for 965 components across all product lines, your yield is 96.5%.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nComponent Yield Rate = (965 Components Produced \/ 1,000 Units Collected) = \u003cstrong\u003e0.965 or 96.5%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this KPI every \u003cstrong\u003eMonday\u003c\/strong\u003e morning for\nthe prior seven days of operation.\u003c\/li\u003e\n\u003cli\u003eSegment yield by component type; it defintely helps isolate processing issues.\u003c\/li\u003e\n\u003cli\u003eIf yield dips below 94%, immediately cross-reference with the Cost Per Component Unit metric.\u003c\/li\u003e\n\u003cli\u003eEnsure donor screening protocols aren't causing high discard rates before processing even starts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 6\n: \u003cspan style=\"color: #126CFF;\"\u003eOperating Cash Cycle (OCC)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Operating Cash Cycle (OCC) tells you exactly how many days cash is tied up in operations, from buying supplies to collecting payment from hospitals. For this blood bank, it measures the time needed to convert perishable inventory—the collected blood—into actual cash receipts. You must target keeping this cycle \u003cstrong\u003eunder 60 days\u003c\/strong\u003e because biological inventory has a short shelf life; slow conversion means higher risk of waste.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDirectly measures working capital efficiency for perishable goods.\u003c\/li\u003e\n\u003cli\u003eSignals immediate liquidity needs based on inventory turnover speed.\u003c\/li\u003e\n\u003cli\u003eHelps justify capital expenditures needed to speed up processing times.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt doesn't reflect profitability; a fast cycle can still lose money.\u003c\/li\u003e\n\u003cli\u003eIt is heavily influenced by hospital payment habits (DSO).\u003c\/li\u003e\n\u003cli\u003eIt ignores the risk of inventory spoilage if not tracked alongside Wastage Rate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor businesses managing high-turnover, regulated inventory like blood products, the benchmark is tight: aim for \u003cstrong\u003eunder 60 days\u003c\/strong\u003e. If your cycle stretches past 75 days, you’re likely holding too much inventory or waiting too long for payments, which is defintely unsustainable here. This metric is key because every day you hold the product increases the chance of it expiring before sale.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReduce Days Inventory Outstanding (DIO) by improving Component Yield Rate to \u003cstrong\u003e95%\u003c\/strong\u003e+.\u003c\/li\u003e\n\u003cli\u003eShorten Days Sales Outstanding (DSO) by mandating \u003cstrong\u003eNet 30\u003c\/strong\u003e terms for hospitals.\u003c\/li\u003e\n\u003cli\u003eIncrease Days Payables Outstanding (DPO) by negotiating longer terms for reagents.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate OCC by adding the time inventory sits waiting (DIO) and the time you wait for payment (DSO), then subtracting the time you take to pay your own vendors (DPO). This gives you the net time cash is out of your bank account.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nOCC = Days Inventory Outstanding (DIO) + Days Sales Outstanding (DSO) - Days Payables Outstanding (DPO)\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eLet’s assume your processing and storage time (DIO) averages \u003cstrong\u003e12 days\u003c\/strong\u003e, reflecting efficient handling of packed red cells. Your average collection period from hospitals (DSO) is \u003cstrong\u003e40 days\u003c\/strong\u003e. You manage to pay for testing kits and bags in \u003cstrong\u003e15 days\u003c\/strong\u003e (DPO). Here’s the quick math on how long your cash is stuck:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nOCC = 12 days (DIO) + 40 days (DSO) - 15 days (DPO) = 37 days\n\u003c\/div\u003e\n\u003cp\u003eThis result of \u003cstrong\u003e37 days\u003c\/strong\u003e is excellent, well below the 60-day target, meaning your working capital is turning over quickly.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview OCC monthly, focusing on the \u003cstrong\u003e60-day\u003c\/strong\u003e threshold as a hard limit.\u003c\/li\u003e\n\u003cli\u003eSegment DSO by hospital client to identify payment outliers immediately.\u003c\/li\u003e\n\u003cli\u003eUse the Component Yield Rate KPI to directly impact DIO efficiency.\u003c\/li\u003e\n\u003cli\u003eEnsure DPO negotiations don't compromise the quality of critical supplies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 7\n: \u003cspan style=\"color: #126CFF;\"\u003eRevenue Mix Concentration\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eRevenue Mix Concentration shows how much of your total money comes from just a few items. For VitalFlow Solutions, this means tracking the combined sales of your top 2 or 3 blood components, like Packed Red Blood Cells (PRC) and Platelets. Monitoring this monthly tells you if you rely too heavily on one or two specific products for survival.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSpot reliance on single, high-volume components early.\u003c\/li\u003e\n\u003cli\u003eGuide inventory planning toward less concentrated revenue streams.\u003c\/li\u003e\n\u003cli\u003eFlag pricing pressure risks on core products before they hurt margins.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt ignores the profitability (margin) of the top products.\u003c\/li\u003e\n\u003cli\u003eIt doesn't show if the top products are growing or shrinking in volume.\u003c\/li\u003e\n\u003cli\u003eA low concentration number might hide poor overall sales performance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized medical supply chains like blood banking, a concentration above \u003cstrong\u003e75%\u003c\/strong\u003e from the top two components is often seen as high risk. Stable, mature operations aim to keep this figure closer to \u003cstrong\u003e60%\u003c\/strong\u003e or lower. Staying below this threshold shows you have successfully diversified your sales across plasma, cryoprecipitate, and other specialized offerings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAggressively market and secure contracts for lower-volume components like specialized plasma types.\u003c\/li\u003e\n\u003cli\u003eAdjust processing schedules to increase the yield of secondary components when demand for the top product dips.\u003c\/li\u003e\n\u003cli\u003eIncentivize hospital procurement teams to diversify their orders away from just PRC.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by taking the revenue generated by your most important products and dividing it by your total sales for the period. This is a simple division problem, but the result is critical for risk assessment.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n(Revenue from Top Products \/ Total Revenue)\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your Total Revenue for the month was \u003cstrong\u003e$5,000,000\u003c\/strong\u003e. If the revenue from Packed Red Blood Cells and Platelets combined was \u003cstrong\u003e$3,800,000\u003c\/strong\u003e, here is the math:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n($3,800,000 \/ $5,000,000) = 0.76\n\u003c\/div\u003e\n\u003cp\u003eThis means your Revenue Mix Concentration is \u003cstrong\u003e76%\u003c\/strong\u003e. You need to know if that \u003cstrong\u003e76%\u003c\/strong\u003e is trending up or down month-over-month.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack this metric on the \u003cstrong\u003e5th business day\u003c\/strong\u003e of every month.\u003c\/li\u003e\n\u003cli\u003eSegment the calculation by client type (e.g., Trauma vs. Oncology centers).\u003c\/li\u003e\n\u003cli\u003eSet a hard ceiling, perhaps \u003cstrong\u003e80%\u003c\/strong\u003e, before triggering a formal risk review.\u003c\/li\u003e\n\u003cli\u003eCompare the trend against the Component Yield Rate (KPI 5) to see if processing efficiency drives concentration.\u003c\/li\u003e\n\u003cli\u003eYou should defintely look at the margin on the top products, not just the revenue share.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49303595942131,"sku":"blood-bank-center-kpi-metrics","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/blood-bank-center-kpi-metrics.webp?v=1782676883","url":"https:\/\/financialmodelslab.com\/products\/blood-bank-center-kpi-metrics","provider":"Financial Models Lab","version":"1.0","type":"link"}